6 Fraser D,Bruskill N,Ito T,et al.Long-term exposure of proximal tubular epithelial cells to glucose induces transforming growth factor-β1 synthesis viaan autocrine PDGF loop.American Journal of Pathology,2003,163:2565-2574.
7 Kam S,van der Geest RN,Verhagen NA,et al.Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-TGF-β-independent pathway.Nephrol Dia Transplant,2004,19:1694-1701.
8 Li JH,Zhu HJ,Huang XR,et al.Smad 7 inhibits fibrotic effect lf TGF-beta on renal tubular epithelial cells by blocking smad 2 activation.J Am Soc Nephrol,2002,13:1464-1472.
9 Han DC,Hoffman BB,Hong SW,et al.Therapy with antisense TGF-β1 oligodeoxynucleotides reduces kidney weight and matrix mRNA in diabetic mice.AmJ Physiol Renal Physiol,2000,278:628-634.
10 Ziyadeh FN,Hoffman BB,Han DC,et al.Long-term prevention of renal insufficiency, excess matrix gene expression and glomerular mesangial matrix expression by treatment with monoclonal anti-TGF-β antibody in db/db diabetic mice.Proc Natl Acad Sci USA,2000,97:8015-8020.
11 Twigg SM,Cao Z,MCL ennan SV,et al.Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.Endocrimology,2002,143:4907-4915.
12 Okada H,Kikuta T,Kobayashi T,et al.Connetive tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis.J Am Soc Nephrol,2005,16:133-143.
13 Wang S,DeNichilo M, Brubeker C,et al.Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.Kidney Int,2001,60:96-105.
14 McLennan SV,Wang XY,Moreno V,et al.Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinade type 1: implications for diabetic nephropathy.Endocrinology,2004,145:5646-5655.
15 张春，朱忠华，刘建社，等.结缔组织生长因子对肾小管上皮细胞转分化的调节机制?中华医学杂志，2005，41：2920-2925.
16 Yokoi H,Mukoyama M,Nagae T,et al.Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis.J Am Soc Nephrol,2004,15:1430-1440.
17 Kelly DJ,Glbert RE.Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy.J Am Soc Nephrol,2001,12:2098-2107.
18 Wang SN,Hirschberg R.Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis.American Journal of Physiology Renal Electrolyte Physiology,2000,278:554-560.
19 Wada T,Furuichi K,Sakai N,et al.Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int,2000,58:1492-1499.
20 Morii T,Fujita H,Narita T,et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy.J Diab Compl,2003,17:11-15.
21 Forte G,Minieri M,Cossa P,et al.Hepatocyte growth factor effects on mesenchymal stem cells:proliferation,migration,and differention.Stem cells,2006,24:23-33.
22 牟姗，张庆怡，倪兆慧，等?肝细胞生长因子受体高糖诱导肾间质成纤维细胞中的表达及意义?中华肾脏杂志，2002，18：171-174.
23 Kagawa T,Takemura G,Kosai K,et al.Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice.Nephron Physiol,2006,102:92-102.
24 Dai C,Yang J,Bastacky S,et al.Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice.J Am Soc Nephrol,2004,15:2637-2647.
25 Wassef L,Kelly DJ,Gilbert RE,et al.Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes.Kidney Int,2004,66:1805.
26 Junaid A,Amara FM.Osteopontin:correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells.Histopathology,2004,44:136-146.
27 Sodhi CP,Phadke SA, Batlle D,et al.Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis:role of osteopontin.Am Physiol Renal Physiol,2001,280:667-674.
